The Business Research Company’s report on the Flow Cytometry In Oncology And Immunology Market provides insights into the global market size, growth rate, regional distribution, competitive landscape, key segments, emerging trends, and strategic opportunities.
Which emerging drivers are set to accelerate the growth of the flow cytometry in oncology and immunology market further?
The increasing prevalence of cancer is expected to propel the growth of flow cytometry in the oncology and immunology market going forward. Cancer is a disease that describes a group of disorders characterized by the uncontrolled growth and spread of abnormal cells in the body. Flow cytometry is a widely used technique in oncology and immunology for studying cancer and immune cells. For instance, in October 2022, in Macmillan Cancer Support, a UK-based healthcare charity organization, 3 million people had cancer in 2020, and it is estimated that it will rise to 3.5 million by 2025, 4 million by 2030, and 5.3 million by 2040. Therefore, the increasing prevalence of cancer is driving the growth of flow cytometry in the oncology and immunology markets.
Access Your Free Sample of the Global Flow Cytometry In Oncology And Immunology Market Report – Get Insights Now!
Flow Cytometry In Oncology And Immunology Market Report 2025, Share Sample
What are the key factors influencing the forecasted market size of the flow cytometry in oncology and immunology industry?
The flow cytometry in oncology and immunology market size has grown rapidly in recent years. It will grow from $2.11 billion in 2024 to $2.33 billion in 2025 at a compound annual growth rate (CAGR) of 10.4%. The growth in the historic period can be attributed to advancements in cancer research, immunology research growth, diagnostic applications, rise in autoimmune diseases, drug development and clinical trials
The flow cytometry in oncology and immunology market size is expected to see rapid growth in the next few years. It will grow to $3.46 billion in 2029 at a compound annual growth rate (CAGR) of 10.4%. The growth in the forecast period can be attributed to integration with genomics and proteomics, growing adoption of single-cell analysis, expanding applications in infectious diseases, rise in cancer incidence, and point-of-care flow cytometry. Major trends in the forecast period include immunophenotyping for immunotherapy, miniaturization of flow cytometry systems, multiparametric analysis, shift towards spectral flow cytometry, and collaborative research initiatives.
Gain Exclusive Market Insights—Customize Your Research Report Today For Fast Delivery!
Flow Cytometry In Oncology And Immunology Market Report 2025, Share Customise
Who are the leading competitors in the flow cytometry in oncology and immunology market?
Major companies operating in the flow cytometry in oncology and immunology market include Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA, Becton Dickinson and Company, Laboratory Corporation of America Holdings, Agilent Technologies Inc., Sartorius AG, Beckman Coulter Inc., Bio-Rad Laboratories Inc., Sysmex Partec GmbH, OPKO Health Inc., Miltenyi Biotec, NeoGenomics Laboratories Inc., Luminex Corporation, Q2 Solutions LLC, DiaSorin S.p.A, BioLegend Inc., Cytek Biosciences Inc., Cell Signaling Technology Inc., Standard BioTools Inc., Sony Biotechnology Inc., NanoCellect Biomedical Inc., Nexcelom Bioscience LLC, CytoReason
Which emerging trends are set to transform the flow cytometry in oncology and immunology market landscape?
Technological advancements are a key trend gaining popularity in flow cytometry in the oncology and immunology market. Major companies operating in flow cytometry in the oncology and immunology markets are adopting new technologies to sustain their position in the market. For instance, in September 2022, Becton Dickinson, and Company, a US-based medical technology provider, launched BD Research Cloud for flow cytometry in oncology and immunology. BD Cloud is a cloud-based software system that simplifies the flow cytometry process for researchers working in various fields, such as immunology, virology, infectious disease, and oncology surveillance, to enable higher-quality studies with quicker time to insight. BD is leveraging innovative technologies like BD Horizon RealYellow and RealBlue Reagents, as well as the newly introduced BD FACSDiscover S8 Cell Sorter with BD CellView Image Technology, to enhance the capabilities of flow cytometry, enabling researchers to optimize and advance their groundbreaking studies. Built on an industry-standard cloud infrastructure, BD Research Cloud is uniquely suited for BD equipment and reagents.
How do different geographies compare in terms of market share and growth potential in the flow cytometry in oncology and immunology market?
North America was the largest region in the flow cytometry in oncology and immunology market in 2024. The regions covered in the flow cytometry in oncology and immunology market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Order Your Report Now For Swift Delivery
Flow Cytometry In Oncology And Immunology Market Report 2025, Share
Which major segments of the flow cytometry in oncology and immunology market are experiencing the fastest growth?
The flow cytometry in oncology and immunology market covered in this report is segmented –
1) By Type: Immunology, Oncology
2) By Technology: Cell-Based Flow Cytometry, Bead-Based Flow Cytometry
3) By Application: Translational Research, Clinical Research
4) By End User: Hospitals, Diagnostic Laboratories, Reference Laboratories, Pharmaceutical And Biotechnology Companies, Academic Research Institutes, Contract Research Organizations, Other End Users
Subsegments:
1) By Immunology: Immune Cell Profiling, Cytokine Detection, T-Cell And B-Cell Analysis, Autoimmune Disease Testing
2) By Oncology: Cancer Cell Analysis, Tumor Microenvironment Studies, Minimal Residual Disease Detection, Biomarker Discovery And Validation
Purchase The Exclusive Report Now To Unlock Valuable Market Insights:
Flow Cytometry In Oncology And Immunology Market Report 2025, Share
How is the flow cytometry in oncology and immunology market defined, and what are its core characteristics?
Flow cytometry is a powerful analytical technique used in oncology and immunology to measure and analyze the physical and chemical characteristics of cells or particles as they flow in a fluid stream through a laser beam. This technology enables the simultaneous quantification of multiple cellular parameters, such as size, granularity, and the expression of surface and intracellular markers, facilitating the study of cell populations and their functions in health and disease.
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: The Business Research Company | LinkedIn
